These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8503142)

  • 41. [Renal clearance technic for individualizing lithium dosage in routine hospital care].
    Klinger E; Steimer JL; Jouvent R; Le Moël G; Mascart JY; Des Lauriers A
    Encephale; 1984; 10(5):223-30. PubMed ID: 6440774
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Population Pharmacokinetic Analyses of Lithium: A Systematic Review.
    Methaneethorn J
    Eur J Drug Metab Pharmacokinet; 2018 Feb; 43(1):25-34. PubMed ID: 28555320
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A feasibility study of the multiple-peak approach for pharmacokinetic screening: population-based investigation of valproic acid relative clearance using routine clinical pharmacokinetic data.
    Yukawa E
    J Pharm Pharmacol; 1995 Dec; 47(12A):1048-52. PubMed ID: 8932693
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection of carbamazepine drug interaction by multiple peak approach screening using routine clinical pharmacokinetic data.
    Yukawa E; Aoyama T
    J Clin Pharmacol; 1996 Aug; 36(8):752-9. PubMed ID: 8877681
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients.
    Swart EL; Zuideveld KP; de Jongh J; Danhof M; Thijs LG; Strack van Schijndel RM
    Br J Clin Pharmacol; 2004 Feb; 57(2):135-45. PubMed ID: 14748812
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Switching from body surface area-based to fixed dosing for the investigational proteasome inhibitor ixazomib: a population pharmacokinetic analysis.
    Gupta N; Zhao Y; Hui AM; Esseltine DL; Venkatakrishnan K
    Br J Clin Pharmacol; 2015 May; 79(5):789-800. PubMed ID: 25377318
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Population pharmacokinetics of phenytoin in Japanese patients with epilepsy: analysis with a dose-dependent clearance model.
    Odani A; Hashimoto Y; Takayanagi K; Otsuki Y; Koue T; Takano M; Yasuhara M; Hattori H; Furusho K; Inui K
    Biol Pharm Bull; 1996 Mar; 19(3):444-8. PubMed ID: 8924916
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epidemiologic investigation of the relative clearance of haloperidol by mixed-effect modeling using routine clinical pharmacokinetic data in Japanese patients.
    Yukawa E; Hokazono T; Funakoshi A; Yukawa M; Ohdo S; Higuchi S; Ichimaru R; Makit T; Matsunaga K; Anai M; Goto Y
    J Clin Psychopharmacol; 2000 Dec; 20(6):685-90. PubMed ID: 11106142
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Population pharmacokinetics of ertapenem in juvenile and old rats.
    Boulamery A; Marsot A; Bruguerolle B; Simon N
    Fundam Clin Pharmacol; 2014 Apr; 28(2):144-50. PubMed ID: 23647486
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Selection of dosing regimen with WST11 by Monte Carlo simulations, using PK data collected after single IV administration in healthy subjects and population PK modeling.
    Fabre MA; Fuseau E; Ficheux H
    J Pharm Sci; 2007 Dec; 96(12):3444-56. PubMed ID: 17854075
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A population pharmacokinetic model of valproic acid in pediatric patients with epilepsy: a non-linear pharmacokinetic model based on protein-binding saturation.
    Ding J; Wang Y; Lin W; Wang C; Zhao L; Li X; Zhao Z; Miao L; Jiao Z
    Clin Pharmacokinet; 2015 Mar; 54(3):305-17. PubMed ID: 25388986
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Population pharmacokinetics of ABT-767 in BRCA1 or BRCA2 mutation carriers with advanced solid tumors or in subjects with high grade serous ovarian, primary peritoneal or fallopian tube cancer.
    Mittapalli RK; Nuthalapati S; Shepherd SP; Xiong H
    Cancer Chemother Pharmacol; 2017 Mar; 79(3):587-594. PubMed ID: 28247011
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Population pharmacokinetics of liposomal amphotericin B in pediatric patients with malignant diseases.
    Hong Y; Shaw PJ; Nath CE; Yadav SP; Stephen KR; Earl JW; McLachlan AJ
    Antimicrob Agents Chemother; 2006 Mar; 50(3):935-42. PubMed ID: 16495254
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Population pharmacokinetic model of lithium and drug compliance assessment.
    Pérez-Castelló I; Mangas-Sanjuan V; González-García I; Gonzalez-Alvarez I; Bermejo M; Marco-Garbayo JL; Trocóniz IF
    Eur Neuropsychopharmacol; 2016 Dec; 26(12):1868-1876. PubMed ID: 27865605
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum cystatin C is a better marker of topotecan clearance than serum creatinine.
    Hoppe A; Séronie-Vivien S; Thomas F; Delord JP; Malard L; Canal P; Chatelut E
    Clin Cancer Res; 2005 Apr; 11(8):3038-44. PubMed ID: 15837759
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The influence of drug-drug interaction and patients' characteristics on valproic acid's clearance in adults with epilepsy using nonlinear mixed effects modeling.
    Vucićević K; Miljković B; Pokrajac M; Prostran M; Martinović Z; Grabnar I
    Eur J Pharm Sci; 2009 Dec; 38(5):512-8. PubMed ID: 19804822
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations.
    Mehrotra N; Tang L; Phelps SJ; Meibohm B
    Pharmacotherapy; 2012 May; 32(5):408-19. PubMed ID: 22488303
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Population pharmacokinetics of oral busulfan in children.
    Schiltmeyer B; Klingebiel T; Schwab M; Mürdter TE; Ritter CA; Jenke A; Ehninger G; Gruhn B; Würthwein G; Boos J; Hempel G
    Cancer Chemother Pharmacol; 2003 Sep; 52(3):209-16. PubMed ID: 12811512
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of a new lithium dosage-prediction technique.
    Dugas JE; Feeney AM
    Clin Pharm; 1983; 2(3):249-52. PubMed ID: 6411414
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Population pharmacokinetics of ciprofloxacin in pediatric patients.
    Rajagopalan P; Gastonguay MR
    J Clin Pharmacol; 2003 Jul; 43(7):698-710. PubMed ID: 12856383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.